Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy

Area of Science:

• Biotechnology
• Immunology
• Materials Science

Background:

• Personalized cancer vaccines aim to elicit a broad immune response against tumor antigens.
• Current strategies often focus on single antigens, potentially limiting epitope coverage.

Purpose of the Study:

• To develop an elegant method for encapsulating whole cancer cells into stable, non-aggregated polyelectrolyte microparticles.
• To evaluate the potential of these encapsulated cancer cells as a platform for cancer immunotherapy.

Main Methods:

• Cancer cells were admixed with mannitol and oppositely charged polyelectrolytes (dextran sulfate and poly-l-arginine).
• The mixture was atomized into a hot air stream to form porous, nonaggregated microparticles.
• In vitro studies assessed particle stability, toxicity, dendritic cell uptake, and antigen cross-presentation.
• Immunogenicity was enhanced by adsorbing a polymer-substituted TLR7-agonist onto the particle surface.

Main Results:

• Polyelectrolyte-enrobed cancer cells formed stable microparticles without releasing intracellular proteins.
• The particles were nontoxic and significantly increased dendritic cell uptake of cell lysate.
• In vitro assays demonstrated the particles' potential to promote antigen cross-presentation by dendritic cells.
• Surface adsorption of a TLR7-agonist further enhanced immunogenicity.

Conclusions:

• Polyelectrolyte encapsulation provides a stable and effective method for preparing whole cancer cell-based vaccine candidates.
• These microparticles show significant potential for enhancing dendritic cell-mediated antigen presentation and cross-presentation.
• This approach offers a promising strategy for developing broader and more effective personalized cancer immunotherapies.